Position in PFE
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$66,966
-$62,791 QoQ
Shares Held
2,781
-39.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,590
of 2,821 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roxbury Financial LLC holds $4,813,828 across 10 Drug Manufacturers - General names. PFE ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,762 | $1,209,405 | |
| 2 | ABBV |
AbbVie Inc.
|
3,915 | $985,170 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,883 | $755,965 | |
| 4 | AMGN |
Amgen Inc
|
1,948 | $705,409 | |
| 5 | NVS |
Novartis AG
|
3,782 | $592,715 | |
| 6 | LLY |
ELI LILLY & Co
|
268 | $321,447 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
948 | $119,770 | |
| 8 | PFE |
Pfizer Inc
This page
|
2,781 | $66,966 |
All Filings in PFE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,966 | 2,781 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $129,757 | 4,621 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $173,553 | 6,970 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $202,081 | 7,931 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $192,611 | 7,946 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $289,560 | 11,427 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $403,786 | 15,220 | Shares | Sole | 2025-01-30 | |
| No filing history on record for this holder in this stock. | ||||||